Pediatr. praxi. 2022;23(6):409-410 | DOI: 10.36290/ped.2022.073

Sharp syndrome

MUDr. Gabriela Takáčová, MBA, prof. MUDr. Jagienka Jautová, PhD., MBA
Klinika dermatovenerológie, Lekárska fakulta Univerzity Pavla Jozefa Šafárika a Univerzitná nemocnica Louisa Pasteura, Košice

Sharp syndrome (mixed connective tissue disease - MCTD) is a rare autoimmune disease combining the clinical symptoms of systemic lupus, systemic sclerosis, polymyositis and rheumatoid arthritis. Variability of clinical manifestations often delays the correct diagnosis. We demonstrate the case report of an 11-year-old patient diagnosed with Sharp syndrome. We point out the importance of immunofluorescence examination with evidence of antinuclear antibodies and their specification in the diagnosis of the disease. Due to the wide spectrum of clinical manifestations, interdisciplinary cooperation is essential.

Keywords: Sharp syndrome, mixed connective tissue disease.

Accepted: November 16, 2022; Published: November 22, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Takáčová G, Jautová J. Sharp syndrome. Pediatr. praxi. 2022;23(6):409-410. doi: 10.36290/ped.2022.073.
Download citation

References

  1. Alves MR, Isenberg DA. "Mixed connective tissue disease": a condition in search of an identity. Clin Exp Med. [Internet]. 2020;20(2):159-166. Available from: https://doi.org/10.1007/s10238-020-00606-7. Go to original source... Go to PubMed...
  2. Sedej K, Toplak N, Praprotnik M, et al. Autoimmune hepatitis as a presenting manifestation of mixed connective tissue disease in a child. Case report and review of the literature. Pediatr Rheumatol Online J. [Internet]. 2015;10;13(1):47. Available from: https://doi.org/10.1186/s12969-015- 0046-4. Go to original source... Go to PubMed...
  3. Ortega-Hernandez OD, Shoenfeld Y. Mixed connective tissue disease: an overview of clinical manifestations, diagnosis and treatment. Best Pract Res Clin Rheumatol. [Internet]. 2012. 26(1):61-72. Go to original source... Go to PubMed...
  4. Štvrtinová V, Ferenčíková Z, Čelovská D. Klasifikácia vas­kulitíd. 2015;7(2):57-61. Available from: https://www.solen.sk/storage/file/article/99ea991cb38c297de5ec213­bb­f30d598.pdf.
  5. Bakošová M, Šteňová E. Diagnostika reumatických chorôb a dôležitosť medziodborovej spolupráce. 2018;15(1):28-33. Available from: https://www.solen.sk/storage/file/article/b6fbb9bca467652a5a1c16bfe1874583.pdf.
  6. Mutasim DF, Adams BB. Immunofluorescence in dermatology. J Am Acad Dermatol. [Internet]. 2001;(45)6:803-822. doi: 10.1067/mjd.2001.117518. Go to original source... Go to PubMed...
  7. Gunnarsson R, et al. Mixed connective tissue disease. Best Pract Res Clin Rheumatol. [Internet]. 2016;(30)1:95-111. Available from: https://doi.org/10.1016/j.berh.2016.03.002. Go to original source... Go to PubMed...
  8. Lundberg IE. The prognosis of mixed connective tissue disease. Rheumatic diseases clinics of North America. [Internet]. 2005;(31)3:535-547. doi: 10.1016/j.rdc.2005.04.005. Go to original source... Go to PubMed...
  9. Ciang Natalia CO, et al. Mixed connective tissue disease- enigma variations? Rheumatology [Internet]. 2017;(56)3:326-333. doi: 10.1093/rheumatology/kew265. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.